Viewing Study NCT06779695


Ignite Creation Date: 2025-12-24 @ 1:59 PM
Ignite Modification Date: 2026-04-03 @ 4:38 PM
Study NCT ID: NCT06779695
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-16
First Post: 2025-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prediction of Systemic Thromboembolism and Bleeding in Atrial Fibrillation Patients With Factor Xa Inhibitor (Apixaban, Rivaroxaban) by Echocardiographic Parameters: Prospective Observational Study (AF-ECHO Study)
Sponsor: Korea University Anam Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2024AN0119
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None UNKNOWN View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View
None OTHER View
None OTHER View